Latest Articles

Publication Date
Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review.

Background/Objectives: Endometriosis and urogenital malformation with uterus didelphys and renal agenesis might occur concomitantly, and the question arises whether both entities are associated with each other. Methods: A literature search …

Published: Dec. 11, 2024, midnight
Frankston Hospital Redevelopment Hits Major Milestone 11 December - Mirage News

Frankston Hospital Redevelopment Hits Major Milestone 11 December Mirage News

Published: Dec. 10, 2024, 11:36 p.m.
Addressing mental health risks in endometriosis patients - Contemporary Obgyn

Addressing mental health risks in endometriosis patients Contemporary Obgyn

Published: Dec. 10, 2024, 10:07 p.m.
Female-Specific Factors Don’t Enhance Common Risk Calculators - TCTMD

Female-Specific Factors Don’t Enhance Common Risk Calculators TCTMD

Published: Dec. 10, 2024, 9 p.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Got A Test Tomorrow? Take A Brisk Walk Now To Boost Your Memory - Medical Daily

Got A Test Tomorrow? Take A Brisk Walk Now To Boost Your Memory Medical Daily

Published: Dec. 10, 2024, 9:08 a.m.
GSK Korea expands indication for Jemperli in endometrial cancer treatment - KBR

GSK Korea expands indication for Jemperli in endometrial cancer treatment KBR

Published: Dec. 10, 2024, 3:13 a.m.
Ovary Removal Could Greatly Raise Some Women's Odds for Alzheimer's - MSN

Ovary Removal Could Greatly Raise Some Women's Odds for Alzheimer's MSN

Published: Dec. 10, 2024, 2:52 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!